Hepatitis B Virus
Cepheid Introduces CE Mark Certified Smart HBV Test for SmartCycler System
Published in Hepatitis Weekly, April 2nd, 2007
Cepheid (NASDAQ:CPHD), a broad-based molecular diagnostics company, announced the European release of the Smart HBV(TM) (Hepatitis B Virus) Assay for clinical diagnostic use on the SmartCycler(R) System. The HBV assay was released as a CE IVD Mark product under the European Directive on In Vitro Diagnostic Medical Devices (Annex II, List A), the most rigorous EU requirement, and is intended for the rapid identification of HBV viral load.
HBV is a virus that attacks the liver. According to the World Health Organization, of the two billion people infected with the virus, more than 350 million will have chronic, lifelong infections. These chronically infected patients are...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2007-04-02)
More Articles from Hepatitis Weekly
- Hepatitis A Virus
The American Liver Foundation Urges Cautious Optimism about CDC Report on Declining Acute Hepatitis Infection Rates - Hepatitis C Virus
Intarcia Raises $50 Million in a Series BB Financing - Hepatitis C Virus
InterMune Updates Expense Forecasts and Development Plans - Hepatitis C Virus
The NHI Drug Reimbursement Price Listing and Launch of the Antiviral Agent "Copegus Tablet 200 mg" for the Treatment of Chronic Hepatitis C - Hepatitis C Virus
Valeant Pharmaceuticals Initiates Taribavirin Phase 2b Clinical Study - Cancer Gene Therapy
Scientists at Shandong University, Institute of Immunology describe research in cancer gene therapy - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
